A retrospective observational cohort study assessing the treatment pattern and outcome of Multiple Myeloma with chromosome translocation in real world setting in the USA
Latest Information Update: 06 Jan 2021
At a glance
- Drugs Bortezomib (Primary) ; Carfilzomib (Primary) ; Cyclophosphamide (Primary) ; Daratumumab (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
Most Recent Events
- 06 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology